DC Circ. Urged To Overturn Endo-Impax Opioid Deal Win
The Federal Trade Commission urged the D.C. Circuit to overturn a lower court's decision that allowed two pharmaceutical companies to continue an alleged pay-for-delay agreement, arguing that the companies are still...To view the full article, register now.
Already a subscriber? Click here to view full article